TSKgel?Amide-80HPLCColumn , phasecarbamoyl,L×I.D.25 cm×2 mm,5 μmparticlesize

Synonym(s):
(2,3-Epoxyphytyl)menaquinone;1a,7a-Dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)naphth[2,3-b]oxirene-2,7-dione;2,3-Epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone;2,3-Epoxyphylloquinone;Phylloquinone oxide

CAS NO.：

Empirical Formula: C31H46O3

Molecular Weight: 466.7

MDL number: MFCD00870307

EINECS: 247-022-9

PRODUCT Properties

• storage temp.: -20°C
• solubility: Chloroform (Sparingly), Ethyl Acetate (Slightly)
• form: Oil
• Boiling point: 561.1±50.0 °C(Predicted)
• Density: 1.019±0.06 g/cm3(Predicted)
• color: Colourless to Pale Yellow
• InChI: InChI=1S/C31H46O3/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-31-29(33)27-19-8-7-18-26(27)28(32)30(31,6)34-31/h7-8,18-20,22-24H,9-17,21H2,1-6H3
• InChIKey: KUTXFBIHPWIDJQ-UHFFFAOYSA-N
• SMILES: O1C2(CC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C(=O)C3=C(C(=O)C12C)C=CC=C3

Description and Uses

Vitamin K is a dietary nutrient essential for the normal biosynthesis of factors that are required for blood clotting. It has also been shown to inhibit cell growth. Vitamin K₁ 2,3-epoxide is the inactive metabolite of vitamin K₁. During clotting, vitamin K₁ is converted to this epoxide form and then rapidly reduced back to the vitamin by a microsomal epoxide reductase. This is referred to as the vitamin K epoxide cycle. Certain anticoagulants target clotting factor synthesis by inhibiting the recycling of vitamin K₁ from the inactive epoxide.

A metabolite of Vitamin K1 (V676080).